Announcement PDF RNS Number : 4755L BSF Enterprise PLC 15 December 2025 15 December 2025 BSF Enterprise PLC ("BSF" or the "Company") Changes to timetable for proposed Equity Fundraise and Capital Reorganisation Further to the Company's announcements and despatch of the Notice of General Meeting on 28 November 2025, the Company provides an update on the proposed Equity Fundraise and Capital Reorganisation. Capitalised terms in this announcement have the same meaning as in the Notice of General Meeting, unless the context indicates otherwise. Equity Fundraise As previously announced, the Equity Fundraise is conditional on, inter alia, the FCA's approval of the Prospectus to be issued by the Company within 180 days from the date of CLN, expiring on 26 May 2026. The Company is seeking to obtain the approval of the Prospectus before 28 February 2026. Update on Capital Reorganisation It is now expected that the record date for the Capital Reorganisation will take place on or around 26 February 2026, and the expected date for CREST to be credited with New Ordinary Shares held in uncertificated form (where applicable) is on or around 27 February 2026. Full details of the proposed Capital Reorganisation are set out in the Notice of General Meeting sent to the Shareholders on 28 November 2025. The Directors' unanimous recommendation for the Shareholders to vote in favour of the Resolutions is unchanged from that included in the Notice of General Meeting. An announcement will be made following the General Meeting to confirm the status of the Resolutions. The Company anticipates that the timetable for the proposed Equity Fundraise and Capital Reorganisation will be as follows: Expected Timetable of Principal Events Publication of Notice of General Meeting and Forms of Proxy 28 November 2025 Latest time and date for receipt of Forms of Proxy and CREST Proxy Instructions for the General Meeting 10.00 a.m. on 15 December 2025 Time and date of the General Meeting 10.00 a.m. on 17 December 2025 Announcement of results of the General Meeting 17 December 2025 Record time and date for Capital Reorganisation 6.00 p.m. on 26 February 2026 Latest time and date for dealing in Existing Ordinary Shares 6.00 p.m. on 26 February 2026 Expected date of Admission and first day of dealings in New Ordinary Shares on the Main Market 27 February 2026 Expected date CREST accounts are to be credited with New Ordinary Shares in uncertificated form 27 February 2026 Despatch of definitive certificate for New Ordinary Shares (in certificated form) By 20 March 2026 END For more information and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: https://bsfenterprise.com/link/PREaXr. For further enquiries, please visit www.bsfenterprise.com or contact: BSF Enterprise PLC Geoff Baker - Executive Director Che Connon - CEO & Director https://bsfenterprise.com/s/a1f22b Shard Capital (Broker) Damon Heath Isabella Pierre 0207 186 9000 0207 186 9927 ISIN of the Ordinary Shares is GB00BHNBDQ51. SEDOL Code is BHNBDQ5. Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43 About BSF Enterprise PLC BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab- grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END MSCGPGWWPUPAGWC